Track the 일양약품 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 일양약품 has recorded 37 insider filings. Market capitalisation: €148.8bn. The latest transaction was reported on 28 May 2026 (Purchase). Among the most active insiders: 정유석. The full history is free.
37
Insider Decl.
n/a
Thresholds
n/a
15 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 16,890 of 29,063 companies
47.3
score / 100
Value
53
Quality
42
FCF yld1.0%
Earn yld4.5%
EV/EBITDA11.4x
ROE7.0%
Gross mgn43%
Net mgn2.5%
Debt/EBITDA5.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
일양약품 es una empresa de salud y farmacéutica que cotiza en el mercado XKRX. Se especializa en el desarrollo y comercialización de productos farmacéuticos.